The Ohio Department of Medicaid (ODM) presented an update this week before the Office of Administration’s Prescription Drug Transparency and Affordability Council. In addition to providing updates on Single PBM Procurement, ODM announced: 

• implementation of SB 265 – permissive provider status for administering immunizations, drugs and DTM under CP; 
• that beginning next week, pharmacies can bill for COVID-19 testing by using an NPI number;  
• that It is delaying the implementation of the planned “supplemental dispensing fee” by allocating spread pricing dollars due to state budget concerns  

For a version of the presentation with audio go to 33:13 here. 

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

The Board of Pharmacy released a notice this week regarding fraudulent verbal and paper prescriptions for promethazine/codeine

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

Rep. Bill Roemer (R) has introduced HB 673. This legislation authorizes licensed pharmacists and pharmacy interns to administer immunizations for COVID-19. Specifically, this measure states that licensed pharmacists and pharmacy interns are authorized to administer COVID-19 immunizations to individuals aged seven and older. Additionally, it allows for pharmacists to conduct COVID-19 diagnostic and antibodies tests. The House Local and State Government Committee heard proponent testimony this week. NACDS is on record supporting the bill. 

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

Governors from Ohio, Kentucky, Indiana, Illinois, Michigan, Minnesota, and Wisconsin have formed a pact for coordinating the reopening of the Midwest regional economy.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

Pharmacists, interns and certified technicians may now administer FDA-approved COVD-19 tests under guidance released this week by the Board of Pharmacy.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

The Board of Pharmacy has issued an emergency rule, effective March 22nd, on the dispensing of chloroquine and hydroxychloroquine. For an FAQ on this issue and other COVID-19 related guidance issued by the board, visit their website.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

The Dept. of Health has issued a COVID-19 Checklist for Pharmacies with recommendations from Director Amy Acton, MD, MPH. For more information, visit the website.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

On November 1, the Bureau of Workers’ Compensation began reimbursing pharmacies for dispensing a drug disposal system to patients receiving an opioid prescription for the first time in the last 12 months. The Bureau’s October 2019 issue of the Provider eNews includes an overview of the program.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

On November 1, the Bureau of Workers’ Compensation began reimbursing pharmacies for dispensing a drug disposal system to patients receiving an opioid prescription for the first time in the last 12 months. The Bureau’s October 2019 issue of the Provider eNews includes an overview of the program.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.